Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1.37M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$9.62M
-
Value change
-
+$8.15M
-
Number of buys
-
15
-
Price
-
$7.01
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2014
16 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2014.
IRADIMED CORP - Common Stock (IRMD) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.37M shares
of 12.7M outstanding shares and own 10.78% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (411K shares), SOPHROSYNE CAPITAL LLC (379K shares), MARXE AUSTIN W & GREENHOUSE DAVID M (210K shares), WASATCH ADVISORS INC (164K shares), GRUBER & MCBAINE CAPITAL MANAGEMENT LLC (74.6K shares), ROYCE & ASSOCIATES LLC (36.3K shares), GOLDMAN SACHS GROUP INC (20.1K shares), Manatuck Hill Partners, LLC (20K shares), CONNORS INVESTOR SERVICES INC (17K shares), and PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. (13.8K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.